GGrantIndex
← Search

NOVEL COMBINATORIAL TARGETED CHIMERIC ANTIGEN RECEPTOR NATURAL KILLER CELL-BASED CELLULAR IMMUNOTHERAPY WITH ADJUVANT IMMUNOMODULATION IN PATIENTS WITH AML

$1,441,140FY2021Defense Health AgencyDOD

New York Medical College, Valhalla NY

Investigators

View source on USAspending →